StockTipsArenaBeta

BUY Marksans Pharma Limited — Prakash Gaba

BUYMarksans Pharma Limited

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))9 Jun 2026via CNBC Awaaz.

Entry₹250Stated
Target₹265
Total upside +6.00% (call closed)
Stop loss₹240-4.00% risk
Exit₹26518 Jun 2026, 9:45 am
Target hit+6.00%0.00%upside left
Follow Prakash Gaba for new calls(28% target hit, 184 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 264 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Sept, 11:28 pm IST
3 supporting0 opposing
Supports the BUY call (3)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·11 Jun · 6d ago

India Ratings and Research revised the outlook for Marksans Pharma Ltd's bank loan facilities to Positive from Stable.

BSE · Company Update·9 Jun · 1w ago

(opens in new tab)

Marksans Pharma Limited is acquiring 100% of Netherlands-based QliniQ B.V., expanding its presence in European markets.

NSE · Press Release·1 Jun · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.